Osteoporosis International
Osteoporosis International (commonly abbreviated as ''Osteoporos. Int.' and subtitled with other metabolic bone diseases) is a multidisciplinary journal run jointly by the International Osteoporosis Foundation and the Bone Health & Osteoporosis Foundation, focused on the diagnosis, prevention, treatment and management of osteoporosis. It was founded in 1990 and is issued monthly, with a 2025 impact factor of 5.4.Osteoporosis International（常用缩写 Osteoporos. Int.，副题为兼载其他代谢性骨病）是国际骨质疏松基金会与美国骨质健康与骨质疏松基金会共同主办的跨学科期刊，聚焦骨质疏松症的诊断、预防、治疗与管理，1990 年创刊并按月刊出版，2025 年影响因子为 5.4。[1]
Scope
- Disciplinary focus: the journal is a multidisciplinary title focused on the diagnosis, prevention, treatment and management of osteoporosis, publishing studies that provide broad insight into metabolic bone diseases and covering multiple populations. Its content types include original research, reviews, educational articles and case reports.学科定位： 期刊是一份关注骨质疏松症诊断、预防、治疗与管理的多学科刊物，发表为骨质疏松及其他骨病提供广泛洞见的研究，涵盖不同人群，刊载体裁包括原创研究、综述、教育性文章与病例报告。
- Audience: the journal serves both ends of the field, addressing clinicians and researchers in osteoporosis while also welcoming laboratory work of direct relevance to human disease. Each year the editorial office selects articles for World Osteoporosis Day.读者对象： 面向临床与基础两端的读者，既服务骨质疏松领域的临床医师与研究者，也欢迎对人类疾病有直接意义的实验室工作，编辑办公室按年度在世界骨质疏松日遴选专文予以推荐。
- Foundation backing: the journal is a joint initiative of the International Osteoporosis Foundation and the Bone Health & Osteoporosis Foundation, each nominating an Editor-in-Chief. The foundation counts 349 patient, medical and research organisations in 152 countries among its members and is the largest non-governmental organisation working on osteoporosis and related musculoskeletal diseases.基金会的关系： 期刊是国际骨质疏松基金会与美国骨质健康与骨质疏松基金会的共同项目，两会各有代表人物出任主编，基金会在 152 个国家拥有 349 个患者、医务与研究团体会员，是骨质疏松及相关肌肉骨骼疾病领域规模最大的非政府组织。
- Sister journal: Archives of Osteoporosis is not an independently run title. It is organised by the same Editors-in-Chief, Associate Editors and Editorial Board as this journal, all of its policies and procedures are those of this journal, and its manuscripts are submitted through this journal's own submission system. What distinguishes it is a regional emphasis on epidemiology, bone-density reference values and bone metabolism.姊妹刊： Archives of Osteoporosis 并非独立办刊的姊妹刊，它与本刊由同一批主编、副主编与编委组织，适用本刊的全部政策与程序，投稿也经由本刊的投稿系统递交，两刊的区别在于 Archives of Osteoporosis 着重刊发带有明确地域视角的流行病学、骨密度参考值与骨代谢方面的观察。
- Open access and review incentives: the journal is hybrid, and authors may publish by subscription or pay to convert to open access. The editorial office also runs a review-credit scheme under which reviewers may claim up to three category 1 continuing medical education credits per review, for at most five reviews and fifteen credits in any calendar year.开放获取与评审激励： 期刊为混合开放获取模式，作者可选择按订阅发表或付费转为开放获取，编辑办公室另设评审学分机制，审稿人每次评审可申报至多 3 个一级继续医学教育学分，每年度最多申报 5 次评审、合计不超过 15 个学分。[2]
History
- 1990: the journal was founded as a product of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the United States. Its first issue was issued under the publishing direction of John A. Kanis and Robert Lindsay, and the founding volume established the journal's focus on osteoporosis and other metabolic bone diseases together with its subtitle.1990年： 期刊创刊，是欧洲骨质疏松基金会与美国国家骨质疏松基金会合作办刊的产物，创刊号由 John A. Kanis 与 Robert Lindsay 两位出版负责人签发，首卷即确立了面向骨质疏松及其他代谢性骨病的定位，副题兼载其他代谢性骨病亦自创刊起沿用。
- Launch positioning: the founding statement defined the journal as a forum for communicating and exchanging current ideas on the diagnosis, prevention, treatment and management of osteoporosis and other metabolic bone diseases, and set out the remit of four content types: original papers reporting progress in all areas of osteoporosis, review articles summarising limited themes in which discussion has reached clear conclusions, educational articles giving information on the progress of a topic of particular interest, and case reports of uncommon or interesting presentations.创刊时的定位： 创刊说明把期刊界定为交流骨质疏松及其他代谢性骨病诊断、预防、治疗与管理新思想的场所，并逐项规定了四类体裁的定位：原创论文报告骨质疏松各领域的进展与结果，综述总结讨论已形成明确结论的有限主题，教育性文章介绍特定议题上的进展，病例报告刊载少见或有意思的临床表现。
- Renaming and expansion: the American foundation was later renamed the Bone Health & Osteoporosis Foundation, and the journal now names both organisations as its sponsors accordingly. The International Osteoporosis Foundation on the European side has been a standing sponsor from the outset, and the scale of its membership has grown steadily over the more than three decades since.基金会的更名与扩容： 美国一侧的基金会后更名为骨质健康与骨质疏松基金会，期刊也随之以新名称标注两会共建关系，欧洲一侧的国际骨质疏松基金会自创刊起即为常设主办方，其会员团体规模在创刊后的三十余年里持续扩大。
- September 2026: the International Osteoporosis Foundation announced that René Rizzoli, emeritus professor of internal medicine and endocrinology at the University Hospitals of Geneva, would take over as Editor-in-Chief of the European office on 1 September 2026, succeeding John A. Kanis, who had held the post since 2008. Dr Rizzoli also becomes European Editor-in-Chief of Archives of Osteoporosis and was previously Editor-in-Chief of Calcified Tissue International, an editor of BONE and an Associate Editor of this journal.2026年9月： 国际骨质疏松基金会宣布由日内瓦大学附属医院荣休内科与内分泌科教授 René Rizzoli 自 2026 年 9 月 1 日起接替 John A. Kanis 出任欧洲分部主编，后者自 2008 年起担任该职达十八年，接任者同时也是姊妹刊 Archives of Osteoporosis 的欧洲分部主编，此前曾任 Calcified Tissue International 主编、BONE 编辑与本刊副主编。
- Recent scale: the journal remains monthly and reached volume 37 in 2026. Its impact factor was 5.4 in 2025 with a five-year impact factor of 5.5, the median time from submission to first decision is 17 days, and annual downloads exceed 2.1 million, placing it near the top of the endocrinology and metabolism category.近年体量： 期刊维持月刊，至 2026 年为第 37 卷，2025 年影响因子 5.4，五年影响因子 5.5，自投稿至首次决定的中位时间为 17 天，全年下载量超过 210 万次，在内分泌学与代谢类期刊中居前列。[3]
Editors
- Two Editors-in-Chief: the journal is led by an Editor-in-Chief for the United States and one for Europe. Felicia Cosman MD, appointed by the Bone Health & Osteoporosis Foundation, leads the American office and has a long record of clinical research and public education in osteoporosis. René Rizzoli MD, appointed by the International Osteoporosis Foundation, leads the European office from September 2026.两位主编： 期刊设美国与欧洲两位主编并各司其职，美国分部主编为 Felicia Cosman 医学博士，由美国骨质健康与骨质疏松基金会任命，长期从事骨质疏松症的临床研究与公众教育工作；欧洲分部主编为 René Rizzoli 医学博士，由国际骨质疏松基金会任命，2026 年 9 月上任。
- A board shared by the two journals: Archives of Osteoporosis shares the same Editors-in-Chief, Associate Editors and Editorial Board with this journal, and authors select between them simply by naming their intended title in the cover letter. When an editor judges after reading a manuscript that it would suit the sister journal better, the authors are offered the option of moving to Archives of Osteoporosis instead.两刊共用的编委： Archives of Osteoporosis 与本刊共用同一套主编、副主编与编委，作者在投稿信中说明拟投刊名即可完成选择，编辑在审读后认为稿件更适合姊妹刊时，也会向作者提出改投 Archives of Osteoporosis 的选项。
- Submission system: manuscripts are filed through the online Editorial Manager system, which the two journals share, as the sister title has no portal of its own. The target journal must be named in the cover letter, and all policies and procedures follow those of this journal.投稿系统： 稿件通过 Editorial Manager 在线系统提交，两刊共用同一投稿入口，姊妹刊不设独立入口，投稿时须在信中注明拟投刊名，全部政策与程序以本刊为准。
- Editorial correspondence: manuscript status and referee reports are answered by the editorial office, and authors who remain dissatisfied may use the journal's appeal and complaint channels as set out in its editorial policies. Selection of editors for each side of the joint initiative is run by the respective executive committee.编审沟通： 稿件状态与审稿意见由编辑部统一回复，作者如对处理结果有异议可经期刊编务政策中的申诉与投诉通道提出，两会的编辑遴选分别由各自执行委员会主持。[4]